PI3K–AKT–mTOR: growth signals and resource use

In one sentence

PI3K–AKT–mTOR signaling links growth cues and available resources to cellular programs such as protein production, metabolism, and recycling.

The intuition

A workshop needs both a request to build and enough supplies. Growth signals resemble the request; nutrients and energy resemble the supplies. This network coordinates them. It is a branching control system with feedback, so a straight arrow diagram is only a starting sketch.

How it works

Phosphoinositide 3-kinase (PI3K) modifies membrane lipids that help recruit signaling proteins. AKT, also called protein kinase B, is a kinase: an enzyme that adds phosphate groups to proteins. Its activation depends on location and phosphorylation at particular sites. Experiments identified roles for PDK1 and mTOR complex 2 in this regulation. Alessi 1997, Sarbassov 2005.

Mechanistic target of rapamycin (mTOR) is another kinase. It works in different protein complexes. mTORC1 integrates growth and nutrient signals and regulates processes including protein synthesis and autophagy. mTORC2 has distinct roles, including a contribution to AKT phosphorylation. Sharing mTOR does not make the two complexes interchangeable.

mTORC1 can promote biosynthesis and restrain parts of the autophagy-initiation machinery when conditions favor growth. Reducing this signal can release that restraint, but completed recycling still depends on the rest of the machinery. Ganley 2009.

Feedback means a downstream change alters an upstream signal. A drug may reduce one output while increasing another through feedback. The network therefore needs measurements at specified proteins, sites, and times.

Why it matters in cancer

Cancer-associated changes can disturb growth signaling. Some tumors depend on a particular branch. Others can compensate through another route. A variant in a network member does not by itself reveal gain of function, loss of function, or drug sensitivity.

An RNA gene-set score summarizes messages related to the pathway. It does not directly measure kinase activity or identify the best point to inhibit.

A worked example

In a fictional culture, an mTORC1-directed perturbation lowers phosphorylation of a protein-production regulator. AKT phosphorylation later increases. This is compatible with a network response involving feedback, rather than proof that the drug failed to touch mTORC1.

Growth remains unchanged. The experiment supports a biochemical effect but has not demonstrated a growth dependence. A second assay, suitable controls, and a survival measurement help separate those conclusions.

Common confusions

Protein amount versus activity: abundance and phosphorylation state are distinct measurements.
mTORC1 versus mTORC2: the complex determines which functions are being tested.
One readout versus the entire pathway: phosphorylated S6 is a downstream clue, not a universal activity meter.
Reduced signaling versus clinical benefit: target engagement is one step in an evidence chain.

How it is measured

Research assays follow phosphorylation at named sites, protein localization, synthesis, recycling, and cell survival. A report should state the specimen, timing, normalization, and comparator. Antibodies and preservation conditions matter. Pair the expected biochemical effect with genetic controls or a second perturbation when testing dependence.

Ligands and receptors explains incoming cues. Autophagy explains the recycling output. Cholesterol homeostasis is another resource-control system. The growth lesson puts these measurements side by side.

Sources

Source check: 2026-10-09. General mechanism education; the worked example is fictional. Expert and learner review pending.